sglt2 inhibitors and glp 1 agonist Benefits of treatment with SGLT2i GLP-1RA based on their direct and SGLT2 Inhibitors and GLP-1 Receptor

The therapeutic efficacy of oral glutathione supplementation is well known to be limited by its low bioavailability due to instability and degradation issues occurring in the digestive tract

Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

* Correspondence: Hanliang Jiang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Discontinue use and consult a physician if any adverse reactions occur